Timothy R. Franson - 21 Feb 2023 Form 4 Insider Report for Paratek Pharmaceuticals, Inc.

Role: Director
Signature: /s/ William M. Haskel, Attorney-in-Fact for Timothy R. Franson
Issuer symbol: N/A
Transactions as of: 21 Feb 2023
Net transactions value: -$13,160
Form type: 4
Filing time: 23 Feb 2023, 13:22:35 UTC
Previous filing: 09 Feb 2023
Next filing: 23 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRTK	Common Stock	Sale	$13,160	-7,000	-8.9%	$1.88	72,000	21 Feb 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Sale of shares to cover personal income tax obligations upon vesting of restricted stock units, pursuant to a Rule 10b5-1 trading plan.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.87 to $1.90, inclusive. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.

Content

Sale of shares to cover personal income tax obligations upon vesting of restricted stock units, pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.87 to $1.90, inclusive. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.